Research-Grade Proteins Global Market Report 2024

The research-grade proteins market size has grown exponentially in recent years. It will grow from $0.91 billion in 2023 to $1.11 billion in 2024 at a compound annual growth rate (CAGR) of 21.1%. The growth observed in the historic period can be attributed to several factors, including increasing research activities, a rise in research and development (R&D) efforts within the pharmaceutical and biotechnology industries, growing demand for personalized medicine, increased investments from governmental bodies and various academic institutes, as well as strategic acquisitions and collaborations.

The research-grade proteins market size is expected to see exponential growth in the next few years. It will grow to $2.4 billion in 2028 at a compound annual growth rate (CAGR) of 21.3%. The forecasted growth can be linked to several factors, such as advancements in proteomics research, the increasing number of clinical trials, the integration of artificial intelligence (AI) and data analytics, the utilization of research-grade proteins in industrial applications, and the rising demand for advanced research tools. Major trends expected in the forecast period encompass growing awareness of innovative technologies, technological advancements in the biotechnology industry, progress in proteomics and genomics, expanding applications in drug development, and the adoption of advanced research tools within the biotechnology and pharmaceutical sectors.

The expansion in clinical trials is set to drive the growth of the research-grade proteins market. Clinical trials are investigations into the safety and efficacy of new medical treatments, interventions, or devices in humans. This increase in clinical trials is spurred by advancements in medical research, the burden of diseases, regulatory shifts, patient demand, and industry investments. Research-grade proteins play a crucial role in clinical trials by serving as vital tools for biomarker development, assay development, drug target identification, quality control, and reference standards, ensuring the precision and reliability of experimental data. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,234 registered clinical trials globally by the end of 2023, marking an increase from 437,512 in 2022. Hence, the rising number of clinical trials is fueling the research-grade proteins market's growth.

Key players in the research-grade proteins market are focusing on developing Cas9 proteins to enhance their functionality and applicability in genome editing and other biotechnological applications. Cas9 proteins facilitate genome editing by acting as molecular scissors that can precisely cut DNA at specific locations determined by a guide RNA (gRNA). For instance, in April 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the Gibco CTS TrueCut Cas9 Protein, a high-quality Cas9 protein manufactured under Good Manufacturing Practice (GMP) conditions. This product is tailored for genome editing applications, providing high purity and functionality crucial for precise CRISPR-based research, thus driving advancements in genetic engineering and therapeutic development.

In January 2022, Thermo Fisher Scientific Inc. completed the acquisition of PeproTech for $1.85 billion, expanding its portfolio of research-grade proteins. This acquisition enables Thermo Fisher Scientific to meet the growing demands of the research community more effectively. PeproTech Inc., a US-based biotechnology company, specializes in manufacturing and supplying high-quality cytokine products.

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the research-grade proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Research-grade proteins are proteins that have been produced and purified to meet high standards of quality and purity specifically for scientific research purposes. These proteins play a crucial role in a wide range of experimental and analytical applications, including studies in molecular biology, biochemistry, cell biology, and drug development. They serve as indispensable tools for investigating protein function, interactions, structure, and for developing novel therapeutic strategies.

The primary products within the category of research-grade proteins include cytokines and growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory proteins, hormones, among others. Cytokines and growth factors are proteins responsible for regulating cell signaling and immune responses within the body. These proteins are typically produced using various host cells such as mammalian cells, bacterial cells, fungi and yeast, insect cells, and others. They find applications across pharmaceutical and biotechnology companies, academic and research institutes, and other scientific settings.

The research-grade proteins market research report is one of a series of new reports that provides research-grade proteins market statistics, including the research-grade proteins industry global market size, regional shares, competitors with research-grade proteins market share, detailed research-grade proteins market segments, market trends, and opportunities, and any further data you may need to thrive in the research-grade proteins industry. This research-grade proteins market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The research-grade proteins market consists of sales of bovine serum albumin (BSA), recombinant human insulin, recombinant human epidermal growth factor (EGF), recombinant human tumor necrosis factor-alpha, recombinant human interferon-gamma (IFN-gamma). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.